BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8614448)

  • 1. US broadens scientific base of controls on carcinogens.
    Reichhardt T
    Nature; 1996 Apr; 380(6576):659. PubMed ID: 8614448
    [No Abstract]   [Full Text] [Related]  

  • 2. [The risk assessment of cancer morbidity in the joint action of carcinogens].
    Shaĭkina OI; Shaĭkin AB; Kon'shina LG
    Gig Sanit; 1999; (1):41-3. PubMed ID: 10199078
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinogenic effects of benzene--a status update and research needs to improve risk assessments: US EPA perspective. Environmental Protection Agency.
    Sonawane B; Bayliss D; Valcovic L; Chen C; Rodan B; Farland W
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):471-2. PubMed ID: 11086954
    [No Abstract]   [Full Text] [Related]  

  • 4. The perils and promise of modern risk assessment: the example of trichloroethylene.
    Kester JE; Clewell HJ
    Clin Occup Environ Med; 2004 Aug; 4(3):497-512, vi-vii. PubMed ID: 15325318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk estimation--an overview: disease risk estimation based upon animal bioassays.
    Gaylor DW
    Drug Metab Rev; 1996; 28(1-2):9-27. PubMed ID: 8744587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
    Scheuplein RJ
    Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A toxicologist's view of cancer risk assessment.
    Rozman KK; Kerecsen L; Viluksela MK; Osterle D; Deml E; Viluksela M; Stahl BU; Greim H; Doull J
    Drug Metab Rev; 1996; 28(1-2):29-52. PubMed ID: 8744588
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment: the default conservatism controversy.
    Barnard RC
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):431-8. PubMed ID: 7480897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drawing the battle lines: tracing the "Science War" in the construction of the chloroform and human health risks debate.
    Driedger SM; Eyles J
    Environ Manage; 2003 Apr; 31(4):476-88. PubMed ID: 12677294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is ionizing radiation regulated more stringently than chemical carcinogens?
    Travis CC; Pack SR; Hattemer-Frey HA
    Health Phys; 1989 Apr; 56(4):527-31. PubMed ID: 2925392
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer risk assessment: evolution of the process.
    Farland WH
    Prev Med; 1996; 25(1):24-5. PubMed ID: 8778755
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory aspects of carcinogenicity studies and the Delaney clause.
    Flamm WG
    Regul Toxicol Pharmacol; 1995 Feb; 21(1):71-4; discussion 81-6. PubMed ID: 7784638
    [No Abstract]   [Full Text] [Related]  

  • 15. Living with and reforming the Delaney Clause.
    Degnan FH; Flamm WG
    Food Drug Law J; 1995; 50(2):235-56. PubMed ID: 10342993
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk assessment. End of an era.
    Anderson C
    Nature; 1991 Sep; 353(6342):289. PubMed ID: 1922329
    [No Abstract]   [Full Text] [Related]  

  • 17. The biotechnology revolution and its regulatory evolution.
    Hoffman DE
    Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives on immunotoxicity regulatory guidelines.
    Harling RJ
    Inflamm Res; 1996 Dec; 45 Suppl 2():S69-73. PubMed ID: 8988405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorine industry says EPA rules ignore good science.
    Reichhardt T
    Nature; 1999 Jun; 399(6738):718. PubMed ID: 10391226
    [No Abstract]   [Full Text] [Related]  

  • 20. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.